נגישות
menu      
חיפוש מתקדם
תחביר
חפש...
הספר "אוצר וולקני"
אודות
תנאי שימוש
ניהול
קהילה:
אסיף מאגר המחקר החקלאי
פותח על ידי קלירמאש פתרונות בע"מ -
Mast cells involvement in the inflammation and fibrosis development of the TNBS-induced rat model of colitis
Year:
2002
Authors :
פינס, מרק
;
.
Volume :
37
Co-Authors:
Xu, X., Dept. of Pharmacology, School of Pharmacy, Hebrew Univ.-Hadassah Med. Sch., P.O. Box 12065, 91120 Jerusalem, Israel
Weksler-Zangen, S., Dept. of Pharmacology, School of Pharmacy, Hebrew Univ.-Hadassah Med. Sch., P.O. Box 12065, 91120 Jerusalem, Israel
Pikarsky, A., Dept. of Pharmacology, School of Pharmacy, Hebrew Univ.-Hadassah Med. Sch., P.O. Box 12065, 91120 Jerusalem, Israel
Pappo, O., Dept. of Pharmacology, School of Pharmacy, Hebrew Univ.-Hadassah Med. Sch., P.O. Box 12065, 91120 Jerusalem, Israel
Wengrower, D., Dept. of Pharmacology, School of Pharmacy, Hebrew Univ.-Hadassah Med. Sch., P.O. Box 12065, 91120 Jerusalem, Israel
Bischoff, S.C., Dept. of Pharmacology, School of Pharmacy, Hebrew Univ.-Hadassah Med. Sch., P.O. Box 12065, 91120 Jerusalem, Israel
Pines, M., Dept. of Pharmacology, School of Pharmacy, Hebrew Univ.-Hadassah Med. Sch., P.O. Box 12065, 91120 Jerusalem, Israel
Rivkind, A., Dept. of Pharmacology, School of Pharmacy, Hebrew Univ.-Hadassah Med. Sch., P.O. Box 12065, 91120 Jerusalem, Israel
Goldin, E., Dept. of Pharmacology, School of Pharmacy, Hebrew Univ.-Hadassah Med. Sch., P.O. Box 12065, 91120 Jerusalem, Israel
Levi-Schaffer, F., Dept. of Pharmacology, School of Pharmacy, Hebrew Univ.-Hadassah Med. Sch., P.O. Box 12065, 91120 Jerusalem, Israel
Facilitators :
From page:
330
To page:
337
(
Total pages:
8
)
Abstract:
Background: Mast cells have been implicated in chronic inflammatory conditions resulting in fibrosis, such as Crohn disease. However, a link between inflammation, fibrosis and mast cells has not been demonstrated in human or animal intestinal diseases. This work was undertaken to analyze whether mast cells play a role in inflammation and fibrosis in the TNBS-induced rat colitis. Methods: Rats were rectally instilled 2,4,6,-trinitrobenzene sulfonic acid in ethanol, and immediately or 4 days later injected daily i.p. with nedocromil sodium, a mast cell stabilizer, compound 48/80, a mast cell activator, or saline. Rats were sacrificed 5 days post-TNBS, or on day 21. Intestinal inflammation and fibrosis were assessed by gross and histopathological evaluation. Colonic mast cell numbers (toluidine blue) and collagen (type I mRNA expression) were evaluated. Mast cell sonicate was added to rat colon fibroblasts. Fibroblast proliferation (3H-thymidine), collagen synthesis (3H-proline) and contractile activity (tridimensional collagen lattice contraction) were then assessed. Results: Nedocromil reduced inflammation and fibrosis possibly by decreasing mast cell numbers and activation and consequent collagen production. Compound 48/80 slightly enhanced the severity of the disease by activating mast cells. Mast cells increased fibroblast proliferation, collagen production and contractile activity. Conclusions: Mast cells are involved in the gastrointestinal tract inflammation and fibrosis of the TNBS-colitis rats.
Note:
Related Files :
animal cell
animal experiment
animal model
Animals
animal tissue
Cell Proliferation
Male
Nedocromil
tritium
עוד תגיות
תוכן קשור
More details
DOI :
10.1080/003655202317284246
Article number:
Affiliations:
Database:
סקופוס
Publication Type:
מאמר
;
.
Language:
אנגלית
Editors' remarks:
ID:
26432
Last updated date:
02/03/2022 17:27
Creation date:
17/04/2018 00:22
You may also be interested in
Scientific Publication
Mast cells involvement in the inflammation and fibrosis development of the TNBS-induced rat model of colitis
37
Xu, X., Dept. of Pharmacology, School of Pharmacy, Hebrew Univ.-Hadassah Med. Sch., P.O. Box 12065, 91120 Jerusalem, Israel
Weksler-Zangen, S., Dept. of Pharmacology, School of Pharmacy, Hebrew Univ.-Hadassah Med. Sch., P.O. Box 12065, 91120 Jerusalem, Israel
Pikarsky, A., Dept. of Pharmacology, School of Pharmacy, Hebrew Univ.-Hadassah Med. Sch., P.O. Box 12065, 91120 Jerusalem, Israel
Pappo, O., Dept. of Pharmacology, School of Pharmacy, Hebrew Univ.-Hadassah Med. Sch., P.O. Box 12065, 91120 Jerusalem, Israel
Wengrower, D., Dept. of Pharmacology, School of Pharmacy, Hebrew Univ.-Hadassah Med. Sch., P.O. Box 12065, 91120 Jerusalem, Israel
Bischoff, S.C., Dept. of Pharmacology, School of Pharmacy, Hebrew Univ.-Hadassah Med. Sch., P.O. Box 12065, 91120 Jerusalem, Israel
Pines, M., Dept. of Pharmacology, School of Pharmacy, Hebrew Univ.-Hadassah Med. Sch., P.O. Box 12065, 91120 Jerusalem, Israel
Rivkind, A., Dept. of Pharmacology, School of Pharmacy, Hebrew Univ.-Hadassah Med. Sch., P.O. Box 12065, 91120 Jerusalem, Israel
Goldin, E., Dept. of Pharmacology, School of Pharmacy, Hebrew Univ.-Hadassah Med. Sch., P.O. Box 12065, 91120 Jerusalem, Israel
Levi-Schaffer, F., Dept. of Pharmacology, School of Pharmacy, Hebrew Univ.-Hadassah Med. Sch., P.O. Box 12065, 91120 Jerusalem, Israel
Mast cells involvement in the inflammation and fibrosis development of the TNBS-induced rat model of colitis
Background: Mast cells have been implicated in chronic inflammatory conditions resulting in fibrosis, such as Crohn disease. However, a link between inflammation, fibrosis and mast cells has not been demonstrated in human or animal intestinal diseases. This work was undertaken to analyze whether mast cells play a role in inflammation and fibrosis in the TNBS-induced rat colitis. Methods: Rats were rectally instilled 2,4,6,-trinitrobenzene sulfonic acid in ethanol, and immediately or 4 days later injected daily i.p. with nedocromil sodium, a mast cell stabilizer, compound 48/80, a mast cell activator, or saline. Rats were sacrificed 5 days post-TNBS, or on day 21. Intestinal inflammation and fibrosis were assessed by gross and histopathological evaluation. Colonic mast cell numbers (toluidine blue) and collagen (type I mRNA expression) were evaluated. Mast cell sonicate was added to rat colon fibroblasts. Fibroblast proliferation (3H-thymidine), collagen synthesis (3H-proline) and contractile activity (tridimensional collagen lattice contraction) were then assessed. Results: Nedocromil reduced inflammation and fibrosis possibly by decreasing mast cell numbers and activation and consequent collagen production. Compound 48/80 slightly enhanced the severity of the disease by activating mast cells. Mast cells increased fibroblast proliferation, collagen production and contractile activity. Conclusions: Mast cells are involved in the gastrointestinal tract inflammation and fibrosis of the TNBS-colitis rats.
Scientific Publication
You may also be interested in